Search results
Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too
Motley Fool· 12 months agoNovavax (NASDAQ: NVAX) investors have been on edge ever since the company fell behind in the...
Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates
Benzinga via Yahoo Finance· 1 year agoNovavax Inc (NASDAQ: NVAX) has initiated a Phase 2 trial for its COVID-19-Influenza Combination...
Novavax Prototype COVID-19 Vaccine Data Shows Benefit Against Variants
Benzinga via Yahoo Finance· 2 years agoNovavax Inc (NASDAQ: NVAX) presented data from the Phase 3 PREVENT-19 trial and Study 307 (Lot...
Novavax's Second Booster With Omicron Adapted COVID-19 Shot Shows Encouraging Immune Responses
Benzinga via Yahoo Finance· 1 year agoNovavax Inc (NASDAQ: NVAX) announced topline results from its Phase 3 trial of updated COVID-19 shot...
What’s in the Novavax Vaccine? Experts Break It All Down
Prevention via Yahoo News· 2 years agoThe Food and Drug Administration has authorized Novavax’s COVID-19 vaccine for use in the U.S....
CDC recommends Novavax Covid vaccine, triggering rollout of 3.2 million doses
NBC Universal via AOL· 2 years agoThe FDA authorized Novavax's Covid vaccine last week. The CDC's recommendation paves the way for 3.2...
A ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon...
Fortune via Yahoo Finance· 2 years agoThe U.S. Food and Drug Administration (FDA) on Wednesday approved the COVID-19 vaccine from American...
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
Novavax CEO eyes next batch of COVID-19 vaccines after CDC approval
Yahoo Finance via AOL· 2 years agoNovavax passed the finish line to gain authorization for its COVID-19 vaccine, and its first...
Novavax says Omicron shot shows strong immune response as second booster
Reuters via Yahoo News· 1 year agoData showed the shot, NVX-CoV2515, produced 1.6 times the amount of neutralizing antibodies in...